Viewing Study NCT04816669


Ignite Creation Date: 2025-12-24 @ 10:51 PM
Ignite Modification Date: 2025-12-30 @ 10:05 AM
Study NCT ID: NCT04816669
Status: COMPLETED
Last Update Posted: 2022-12-23
First Post: 2021-03-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults
Sponsor: BioNTech SE
Organization: